Morphosys AG(MOR)

18.96+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Morphosys AG
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.morphosys.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
MorphoSys AG成立于1998年3月3日，是一家后期生物制药公司，致力于为患有严重疾病的患者开发创新和差异化疗法。基于其在治疗性抗体发现，发电和工程领域的专有技术平台和领先地位，该公司与其合作伙伴一起参与了100多种治疗性产品的开发。他们广泛的管线跨越两个业务部分：专有开发以及合作发现，该公司根据合作伙伴确定的目标为其制药和生物技术行业的合作伙伴生成候选产品。该公司目前在临床开发中有28种产品候选产品，包括最先进的专利产品候选产品MOR208，用于治疗复发或难治性弥漫大B细胞淋巴瘤。
- 08-16
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 07-25
  自愿退市
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
- 06-21
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 06-18
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 06-10
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 05-28
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 04-18
  超过5%披露
  Form SC 13D - General statement of acquisition of beneficial ownership
  Form SC 13D - General statement of acquisition of beneficial ownership
- 03-13
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 03-08
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 03-06
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 02-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-26
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-04-28
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-03-15
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-10-25
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments